0000905148-24-001090.txt : 20240403
0000905148-24-001090.hdr.sgml : 20240403
20240403214350
ACCESSION NUMBER: 0000905148-24-001090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amado Rafael
CENTRAL INDEX KEY: 0001662119
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38205
FILM NUMBER: 24821450
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zai Lab Ltd
CENTRAL INDEX KEY: 0001704292
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
BUSINESS PHONE: 862161632588
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
4
1
form4.xml
X0508
4
2024-04-01
0001704292
Zai Lab Ltd
ZLAB
0001662119
Amado Rafael
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100
CAMBRIDGE
MA
02142
true
See Remarks
false
Stock Options (Right to Buy)
16.72
2024-04-01
4
A
0
120141
0
A
2034-04-01
American Depositary Shares
120141
120141
D
Restricted Share Units
2024-04-01
4
A
0
78092
0
A
American Depositary Shares
78092
78092
D
Each Stock Option is exercisable for one American Depositary Share ("ADS"), which represents ten Ordinary Shares of the issuer.
The option vests in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service.
Each ADS represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting.
President, Head of Global Oncology Research and Development
/s/ Bruce Blefeld, Attorney-in-Fact
2024-04-03